IDH1 and central nervous system cancer: In the present study, we confirmed an association between volume-based 11C-MET PET quantification metrics and IDH mutational status for untreated glioma patients and further constructed a novel and intuitive statistical model to help clinicians and radiologists non-invasively predict glioma IDH mutation.